A novel bispecific antibody targeting EGFR and cMet is effective against EGFR inhibitor-resistant lung tumors
Were seeing an increase in humanizing, compassionate portrayals of people in larger bodies in GLP-1 weight-loss advertising, meanwhile just the presence of GLP-1s is reinforcing the idea that fat bodies are something that need to be fixed, i.e., weight stigma
The right plan, at the right time, might make all the difference
The company facilitates access to certain medicines, including new launches, through legally permissible channels such as named patient import, strictly against valid prescriptions and in accordance with applicable laws and regulatory requirements
Based on these observations, the GLP-1 RAs have exploded in popularity for treating obesity and helping people lose weight, with two medications approved in the U.S
Starting on a lower dose helps your body build tolerance, especially to stomach-related side effects such as nausea, vomiting and diarrhoea